414 related articles for article (PubMed ID: 15998711)
21. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
23. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
24. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
Vellaichamy E; Zhao D; Somanna N; Pandey KN
Physiol Genomics; 2007 Oct; 31(2):193-202. PubMed ID: 17566078
[TBL] [Abstract][Full Text] [Related]
25. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure.
Holtwick R; Gotthardt M; Skryabin B; Steinmetz M; Potthast R; Zetsche B; Hammer RE; Herz J; Kuhn M
Proc Natl Acad Sci U S A; 2002 May; 99(10):7142-7. PubMed ID: 11997476
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
27. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
[TBL] [Abstract][Full Text] [Related]
28. ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart.
Li Y; Takemura G; Okada H; Miyata S; Kanamori H; Maruyama R; Esaki M; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H946-53. PubMed ID: 17028164
[TBL] [Abstract][Full Text] [Related]
29. β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice.
Tauscher S; Nakagawa H; Völker K; Werner F; Krebes L; Potapenko T; Doose S; Birkenfeld AL; Baba HA; Kuhn M
Cardiovasc Diabetol; 2018 Jul; 17(1):103. PubMed ID: 30016962
[TBL] [Abstract][Full Text] [Related]
30. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models.
Pandey KN; Oliver PM; Maeda N; Smithies O
Endocrinology; 1999 Nov; 140(11):5112-9. PubMed ID: 10537139
[TBL] [Abstract][Full Text] [Related]
31. Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Kishimoto I; Yamahara K; Osaki T; Minamino N; Horio T; Sawai K; Kawano Y; Miyazato M; Sata M; Kohno M; Nakao K; Kangawa K
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1516-21. PubMed ID: 19628785
[TBL] [Abstract][Full Text] [Related]
32. Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct.
Cameron VA; Rademaker MT; Ellmers LJ; Espiner EA; Nicholls MG; Richards AM
Endocrinology; 2000 Dec; 141(12):4690-7. PubMed ID: 11108284
[TBL] [Abstract][Full Text] [Related]
33. Left but not right cardiac hypertrophy in atrial natriuretic peptide receptor-deficient mice is prevented by angiotensin type 1 receptor antagonist losartan.
Holtwick R; Baba HA; Ehler E; Risse D; Vobeta M; Gehrmann J; Pierkes M; Kuhn M
J Cardiovasc Pharmacol; 2002 Nov; 40(5):725-34. PubMed ID: 12409981
[TBL] [Abstract][Full Text] [Related]
34. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
35. Effect of AT2 blockade on cardiac hypertrophy as induced by high dietary salt in the proatrial natriuretic peptide (ANP) gene-disrupted mouse.
Angelis E; Tse MY; Adams MA; Pang SC
Can J Physiol Pharmacol; 2006 Jun; 84(6):625-34. PubMed ID: 16900247
[TBL] [Abstract][Full Text] [Related]
36. Effects of cardiac hormones on arterial pressure and sodium excretion in NPRA knockout mice.
Dietz JR; Landon CS; Nazian SJ; Vesely DL; Gower WR
Exp Biol Med (Maywood); 2004 Sep; 229(8):813-8. PubMed ID: 15337836
[TBL] [Abstract][Full Text] [Related]
37. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.
Rubattu S; Bigatti G; Evangelista A; Lanzani C; Stanzione R; Zagato L; Manunta P; Marchitti S; Venturelli V; Bianchi G; Volpe M; Stella P
J Am Coll Cardiol; 2006 Aug; 48(3):499-505. PubMed ID: 16875975
[TBL] [Abstract][Full Text] [Related]
38. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
[TBL] [Abstract][Full Text] [Related]
39. Importance of Endogenous Atrial and Brain Natriuretic Peptides in Murine Embryonic Vascular and Organ Development.
Tokudome T; Kishimoto I; Shindo T; Kawakami H; Koyama T; Otani K; Nishimura H; Miyazato M; Kohno M; Nakao K; Kangawa K
Endocrinology; 2016 Jan; 157(1):358-67. PubMed ID: 26517044
[TBL] [Abstract][Full Text] [Related]
40. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.
Kuhn M
Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
